Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IJH vs GSK✓SelectedUSD · GSKIJH vs GSK performance historyLatest closeAs of-2.68%11/20
Stock and ETF performance explorer

IJH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+966.7%
GSK return
+177.2%
Excess return
+789.6%
Maximum drawdown
-55.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.7%-0.1%-2.6%-2.6%
7D-7.0%-5.3%-1.7%-4.9%
30D-6.5%-3.7%-2.9%-5.2%
3M-9.9%-7.3%-2.6%-7.5%
6M-5.2%-4.2%-1.0%-4.4%
YTD+4.8%+0.9%+3.9%+2.7%
1Y+11.6%+7.3%+4.3%+6.6%
3Y+40.3%+52.7%-12.4%+11.3%
5Y+28.6%+40.1%-11.5%+3.8%
10Y+147.7%+98.7%+49.0%+68.0%
All+966.7%+177.2%+789.6%+464.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling